Evaluating S1P as a therapeutic target against aggressive osteosarcoma and exploring computer science integration in wet-lab research

Bozzini, Nicolò (2026) Evaluating S1P as a therapeutic target against aggressive osteosarcoma and exploring computer science integration in wet-lab research, [Dissertation thesis], Alma Mater Studiorum Università di Bologna. Dottorato di ricerca in Scienze biomediche e neuromotorie, 38 Ciclo.
Documenti full-text disponibili:
[thumbnail of bozzini_nicolò_tesi.pdf] Documento PDF (English) - Accesso riservato fino a 16 Maggio 2029 - Richiede un lettore di PDF come Xpdf o Adobe Acrobat Reader
Disponibile con Licenza: Creative Commons: Attribuzione - Non Commerciale - Non Opere Derivate 4.0 (CC BY-NC-ND 4.0) .
Download (4MB) | Contatta l'autore

Abstract

Osteosarcoma (OS) is the most common paediatric bone cancer, characterized by aggressive growth, early metastasis, and poor clinical outcomes. OS develops within an acidic tumour microenvironment (TME), which promotes malignant progression, therapeutic resistance, and immune evasion. Identifying molecular pathways associated with tumour acidosis may therefore reveal novel therapeutic targets. Among the adaptations to acidosis, OS cells accumulate intracellular lipid droplets containing bioactive sphingolipids such as sphingosine 1-phosphate (S1P), a potent pro-tumourigenic signalling molecule. However, the relationship between acidosis, S1P signalling, and epigenetic regulation in OS remains poorly understood. This thesis investigated the role of S1P in the acidic OS microenvironment, focusing on its epigenetic activity and therapeutic potential. A literature review identified nuclear S1P-mediated epigenetic regulation as a promising mechanism linking acidosis to tumour aggressiveness through activation of the FOS oncogene. Using 143B OS spheroids, we demonstrated that both extracellular acidosis and S1P increased histone H3 acetylation, working synergistically in combination. These changes were associated with increased FOS expression and nuclear localization of c-Fos. Silencing or pharmacological inhibition of sphingosine kinase 2 (SphK2), the enzyme responsible for nuclear S1P production, abolished these effects and reduced OS clonogenicity. Analysis of patient samples further supported the clinical relevance of this pathway through co-expression of SphK2 and the acidosis-associated marker Lamp2. Collectively, these findings identify SphK2-dependent S1P signalling as a potential therapeutic target in acidic OS. In parallel, this thesis explored accessible artificial intelligence (AI) tools for translational cancer research. Digital pathology workflows were implemented to quantify immune infiltration in OS samples, a preliminary machine learning model was developed to predict immune infiltrates from histological images, and an AI agent was created to identify potential research collaborations through automated literature analysis. Together, these approaches demonstrate how accessible AI methodologies can complement experimental oncology and support future investigations of the OS immune microenvironment.

Abstract
Tipologia del documento
Tesi di dottorato
Autore
Bozzini, Nicolò
Supervisore
Co-supervisore
Dottorato di ricerca
Ciclo
38
Coordinatore
Settore disciplinare
Settore concorsuale
Parole chiave
Sphingosine-1-phosphate; osteosarcoma; tumour microenvironment; epigenetics; machine learning
Data di discussione
8 Luglio 2026
URI

Altri metadati

Gestione del documento: Visualizza la tesi

^